Bio-Techne (TECH) Return on Capital Employed (2010 - 2026)
Bio-Techne (TECH) recorded quarterly Return on Capital Employed of 6.45% in Q1 2026, up 31.49% quarter-over-quarter from 4.91% in Q4 2025, and down 46.0% on a YoY basis from 11.95% in Q1 2025.
Bio-Techne (TECH) Return on Capital Employed (2010 - 2026) Analysis & Trends
Bio-Techne's Return on Capital Employed history runs 17 years deep, the most recent figure standing at 6.45% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 46.0% year-over-year to 6.45%; the TTM figure through Mar 2026 stood at 6.45% (down 46.0% YoY), while the FY2025 annual figure was 4.17%, down 406.0% from the prior year.
- Return on Capital Employed was 6.45% for Q1 2026 at Bio-Techne, up from 4.91% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 13.98% in Q2 2022 to a low of 4.22% in Q2 2025.
- Historically, Return on Capital Employed has averaged 9.43% across 5 years, with a median of 9.91% in 2024.
- The sharpest annual moves came in 2022 and 2024: Return on Capital Employed surged 260 bps in 2022, then tumbled 422 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 13.25% in 2022, then fell by 22 bps to 10.3% in 2023, then fell by 24 bps to 7.88% in 2024, then sank by 38 bps to 4.91% in 2025, then jumped by 31 bps to 6.45% in 2026.
- The last three Return on Capital Employed figures came in at 6.45% (Q1 2026), 4.91% (Q4 2025), and 4.59% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 6.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.45% |
| Dec 31, 2025 | 4.91% |
| Sep 30, 2025 | 4.59% |
| Jun 30, 2025 | 4.22% |
| Mar 31, 2025 | 6.91% |
| Dec 31, 2024 | 7.88% |
| Sep 30, 2024 | 7.40% |
| Jun 30, 2024 | 8.10% |
| Mar 31, 2024 | 9.91% |
| Dec 31, 2023 | 10.30% |
| Sep 30, 2023 | 11.62% |
| Jun 30, 2023 | 12.00% |
| Mar 31, 2023 | 12.18% |
| Dec 31, 2022 | 13.25% |
| Sep 30, 2022 | 13.26% |
| Jun 30, 2022 | 13.98% |
| Mar 31, 2022 | 13.33% |
| Dec 31, 2021 | 12.32% |
| Sep 30, 2021 | 11.79% |
| Jun 30, 2021 | 11.74% |